Article

Kinetics of naturally induced binding and neutralizing anti-SARS-CoV-2 antibody levels and potencies among Kenyan patients with diverse grades of COVID-19 severity

2022-10-05

Abstract excerpt

<h4>Background</h4> Given the low levels of COVID-19 vaccine coverage in Sub-Saharan Africa, despite high levels of natural SARS-CoV-2 exposures, strategies for extending the breadth and longevity of naturally acquired immunity are warranted. Designing such strategies will require a good understanding of natural immunity. <h4>Methods</h4> We used ELISA to measure whole-spike IgG and spike-receptor binding domain (...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b3da5cee-df7b-587d-918e-468f73420d79
DOI: 10.1101/2022.10.05.22280716

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Kinetics of naturally induced binding and neutralizing anti-SARS-CoV-2 antibody levels and potencies among Kenyan patients with diverse grades of COVID-19 severityDOI 10.1101/2022.10.05.22280716Read

Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational studySemantic proximity Read

Determinants of long-term SARS-CoV-2 immune responses in asymptomatic-to- moderate COVID-19 patients in sub-Saharan AfricaSemantic proximity Read

Measurement of binding antibodies to SARS-CoV-2 variants elicited by natural infection and COVID-19 vaccines in a sub-Saharan African populationSemantic proximity Read

Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severitySemantic proximity Read

Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in Congolese individualsSemantic proximity Read

Rapid generation of neutralizing antibody responses in COVID-19 patientsSemantic proximity Read

Impact of SARS-CoV-2 exposure history on antibody kinetics and correlates of protection in The GambiaSemantic proximity Read

Variant-specific antibody correlates of protection against SARS-CoV-2 Omicron symptomatic and overall infectionsSemantic proximity Read

Neutralising antibodies predict protection from severe COVID-19Semantic proximity Read

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.Semantic proximity Read

Predicting COVID-19 Vaccine Efficacy from Neutralizing Antibody LevelsSemantic proximity Read

Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021–June 2022Semantic proximity Read